About

Dr. Stefano Cianci is a pioneering gynecologic surgeon whose research focuses on advancing minimally invasive and robotic surgery for the treatment of gynecologic malignancies and benign conditions. His major contributions include systematic evaluations of single-port robotic platforms, such as the Senhance™ system, demonstrating their feasibility and safety in complex procedures like total hysterectomy in obese patients and pelvic exenteration. He has also led critical investigations into minimally invasive secondary cytoreduction combined with HIPEC for recurrent ovarian cancer, showing improved perioperative outcomes compared to open surgery. With over 400 citations across his most-cited works, his meta-analyses on sentinel lymph node detection and uterine manipulator use in endometrial cancer have shaped clinical guidelines. Notably, he co-authored the ROMANHY trial, a multicentric randomized study assessing the impact of uterine manipulators on lymph vascular space invasion. Dr. Cianci’s work bridges surgical innovation and evidence-based practice, making him a leading voice in the evolution of robotic gynecology.

Research Focus

Key Achievements

12
H-Index
18
Papers
484
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Single‐Port Platform in General, Urologic, and Gynecologic Surgeries: A Systematic Review of the Literature and Meta‐analysis
77 citations · 2019
📈 Most Prolific Year: 2022 (3 Papers)
🤝 Key Collaborators: 75
🏛 Institutions: Agostino Gemelli University Polyclinic, Università Cattolica del Sacro Cuore, University of Messina, Azienda Ospedaliera Universitaria Policlinico "G. Martino", University of Campania "Luigi Vanvitelli", Policlinico Universitario di Catania

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago